Keratosis Follicularis Spinulosa Decalvans, (KFSD, OMIM 308800) is a rare genetic disorder characterized by development of hyperkeratotic follicular papules on the scalp followed by progressive alopecia of the scalp, eyelashes and eyebrows. Associated eye findings include photophobia in childhood and corneal dystrophy. Due to the genetic and clinical heterogeneity of similar disorders, a definitive diagnosis of KFSD is often challenging. Towards identification of the causative gene we re-analysed a large Dutch KFSD family. 1M SNP arrays redefined the locus to a 2.9 Mb region at Xp22.12-Xp22.11.
. These Dutch cases belonged to a large family that was described by Lameris (Lameris, 1905) under the name 'Ichthyosis Follicularis'.
In the two large pedigrees described by Lameris and Siemens (Lameris, 1905; Siemens HW, 1926) , inheritance is clearly X-linked. However, generally, 50% of carrier females show symptoms of KFSD, which made Siemens postulate that inheritance in KFSD was of the X-linked intermediate type. More X-linked pedigrees have been described (Porteous et al., 1998) . However inheritance is not always clear and isolated cases and autosomal dominant inheritance (i.e. male-to male transmission) has been described as well (Baden and Byers, 1994; Castori et al., 2009; Kuokkanen, 1971; Oosterwijk et al., 1997) . KFSD manifests in infancy or early childhood with thorny keratotic follicular papules, progressive alopecia of the scalp, eyelashes and mainly lateral parts of the eyebrows with variable degrees of inflammatory change. Ocular abnormalities such as photophobia in childhood, punctate defects of the cornea, corneal dystrophy and blepharitis are common findings. Hyperkeratosis of elbows, knees, palms and soles as well as nail dystrophy may occur (Oosterwijk et al., 1997; Rand and Baden, 1983 ; Siemens HW, F o r P e e r R e v i e w #308205), keratosis pilaris atrophicans and atrophoderma vermiculatum. (Oranje et al., 1994) . The question remains whether these syndromes are in actual fact variations of the same entity or truly independent disorders.
Using linkage analysis in the Dutch KFSD family, the locus was mapped to Xp21.2-22.2 (Oosterwijk et al., 1992b) . Subsequently, the disease location was narrowed down to Xp22.13-p22.2 (Oosterwijk et al., 1995) and later refined to Xp22.13-p22.11 (Oosterwijk et al., 1997) . This locus was confirmed in an X-linked family from the UK (Porteous et al., 1998) , but lack of informative crossovers prevented detection of the KFSD gene. In 2002, spermidine/spermine N(1)-acetyltransferase (SSAT OMIM #313020) was postulated as the causative gene for KFSD (Gimelli et al., 2002) . However, the SAT1 gene is not included in the Dutch KFSD interval.
In order to identify the causative gene, we studied the large Dutch family and some other families with a clinical diagnosis of KFSD using new molecular tools. 1M
SNP arrays were used to refine the locus and to exclude the involvement of large deletions and duplications. Subsequently, genes in the candidate gene interval were screened for possible pathogenic variants using High Resolution Melting curve Analysis (HRMA).
Here, we show that KFSD patients carry mutations in the MBTPS2 gene and that this affects the normal function of the protein by lowering MBTPS2 activity. While this work was in progress, deficiencies in the MBTPS2 gene were shown to also cause IFAP syndrome (Oeffner et al., 2009) . Together this sheds new light on the genetic and clinical heterogeneity of these related disorders.
Deleted: IFAP was first described by Mcleod (Macleod and Collins, 1908) 
Study subjects
An extended multigenerational Dutch pedigree with 21 affected males, 15 unaffected males and 12 female carriers was available for molecular analysis (Figure 1a ). Female carriers showed a variable phenotype ranging from severely affected to total absence of KFSD symptoms (van Osch et al., 1992) .
Other families and cases with a clinical diagnosis of KFSD were available for MBTPS2 analysis. Two families showed a clear X-linked mode of inheritance, confirmed by microsatellite marker analysis: a family from the USA as seen by one of us (unpublished data V.P.Sybert ), and a family from the UK that was published previously (Herd and Benton, 1996; Porteous et al., 1998) . The American family ( Figure 1b ) consisted of five affected males, five unaffected males and three carrier females. Four individuals were available for DNA analysis. Seven family members from the UK family (pedigree available in Herd and Benton et al, 1996) (Herd and Benton, 1996) were available for DNA analysis. Clinical features and MBTPS2 genotypes are summarized in Table 1 .
DNA and RNA analysis DNA was extracted from whole blood following standard protocols. Total RNA was extracted from whole blood lymphocytes and from cultured fibroblasts using RNAbee Tm (Bioconnect). cDNA was made using 1ug of total RNA according to standard protocols. Fibroblasts were cultured in DMEM (Gibco) with 10% FCS, 1% Penicilin + Deleted: Concentrations and 260/280 ratios were measured using a nanodrop (ND 1000, Thermo Scientific).
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Array platforms
For SNP typing and CNV analysis, the Illumina Human1M BeadChip (Illumina Inc., San Diego, CA, USA) was used and a total of 750 ng DNA was processed according to the manufacturer's instructions. SNP copy number (log R ratio) and B-allele frequency were assessed using the software programs BeadStudio version 3.2 (Illumina).
High Resolution Melting Curve Analysis
High Resolution Melting curve Analysis (HRMA) was used as a pre-mutation screening in the Dutch KFSD family. Primers were designed to cover all exons and intron/exon boundaries of the 14 candidate genes (Fig 2) using Lightscanner primer design (Idaho). Known SNPs were avoided as much as possible. Sequences are available on request. Fragments were amplified using a touchdown PCR (65 0 -59 0 ) directly followed by melting (LightCycler 480 Roche). To detect possible heteroduplex formation, patient DNA was mixed with DNA from unaffected male individuals in a 1:1 ratio. Melting curves of mixed samples were compared to those of unmixed samples and healthy controls. Samples showing aberrant melting curves were selected for direct sequence analysis.
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X-chromosome inactivation
The methylation status of the X-chromosome was determined using the Androgen Receptor (AR) locus (Kubota et al., 1999) . The maternal and paternal X chromosomes are distinguished by polymorphisms of a CAG repeat element in the AR gene while Xinactivation level is determined by the methylation of CpG dinucleotides in the AR gene.. culturing. Cells were harvested at day 6 and cells were counted in a hemocytometer. The complementation assay was performed as described by Oeffner et al (Oeffner et al., 2009 ).
Complementation assay
Luciferase Reporter Assays
This assay, an indirect measure of the ability of MBTPS2 cDNAs to restore sterolregulated transcriptional activity in transfected M19 cells with a firefly pSRE-Luciferase reporter plasmid, was performed as described by Oeffner et al (Oeffner et al., 2009; Zelenski et al., 1999) . In short, CHO-K1-M19 cells were transfected with expression plasmids without MBTPS2 cDNA insert, wild-type or mutant MBTPS2 and a reported plasmid (pSRE-GL4.23) in which the luciferase reporter gene is under transcriptional control of the human LDL receptor promotor (Sterol Regulatory Element, SRE) and a Renilla luciferase plasmid (pRL-SV40) as a transfection control. Cells were cultured for . DAP+ was used to develop staining and sections were counterstained using Haematoxylin.
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RESULTS
Descendants of an extended Dutch pedigree (Oosterwijk et al., 1992a; Oosterwijk et al., 1992b; Oosterwijk et al., 1995; Oosterwijk et al., 1997) were subject to clinical and molecular analysis. First, to map the locus more accurately we analysed several members of each family using 1M SNP arrays. Analysis included the critical recombinants VII-12
and VI-29 ( Figure 1a Dutch Pedigree) which defined the borders of the KFSD locus.
Disease segregation fully matched with published linkage data (Oosterwijk et al., 1997 ).
In addition we were able to redefine the region more precisely to a ~2.9 Mb region with the proximal breakpoint between chrX:19390769G>C and rs5955562 and the distal breakpoint between rs6528097 and rs4408025. Copy number variations (>5 consecutive SNPs) were not detected in this region or in any other genomic region, thereby excluding deletions or duplications as a possible genetic cause.
This refined region in Xp22.12-Xp22.11 contains 14 genes ( Figure 2 ). HighResolution Melting curve Analysis (HRMA) was used to screen these genes for sequence variants ( Figure 2 ) in patients versus controls. Aberrant melt curves in one or more samples and thereby sequence variants were detected in 4 genes (Supp. Table S1 ). The variant in the MBTPS2 gene was considered as the most promising disease-causing variant since it occurred in all affected males and changes a highly conserved amino acid (p.Asn508Ser) (Figure 2 ).
The c.1523A>G variant showed full co-segregation with the disease in the Dutch family ( Figure 3a) . We analysed the MBTPS2 gene in two other KFSD families with an established X-linked inheritance, an UK family reported by Porteous et al (Herd and Benton, 1996; Porteous et al., 1998) . Table S2 ).
Skin biopsies and whole blood samples were obtained from 7 individuals from the Dutch family. RNA analysis showed the expected variant in the RNA (c.1523A>G).
Since the variant lies in the last exon we analysed a potential effect on RNA splicing using 3'RACE, but no effect could be detected. Carrier females showed variability in the expression of the mutated and the wild type allele (Figure 3b ). To exclude RNA stability differences, the allelic expression was correlated to the level of X-inactivation (Xi) using a methylation assay. Imbalances in allelic expression perfectly matched with skewed levels of X-inactivation and more interestingly with the clinical phenotype. This was most striking in a mother (VI-19) and her two daughters (VII-10 and VII-11). The mother preferentially expresses the mutant allele and has a moderate phenotype. One of her two daughters without any symptoms of KSFD only expresses the wild-type allele, while the second, mildly to moderately affected daughter expresses both the disease-and wild-type allele ( Table 2) .
Expression of MBTPS2 mRNA in fibroblasts was studied by qRT-PCR using RNA isolated from two male KFSD patients and five carrier females. MBTPS2 has two transcripts. The shorter transcript ranges from exon 1 up to exon 7, the full length transcript ranges from exon 1 up to exon 11. Using transcript specific primers, no significant differences in expression of the shorter or longer transcripts were found in fibroblast derived mRNA from carrier females (data not shown). Significantly higher expression of the full length MBTPS2 transcript was found in carrier females (n=3) compared to controls (n=5), while there are no significant differences in expression in affected males (n=2) compared to controls (n=3) (Supp. Figure S1 ). Figure S4 ) are in agreement with these findings and show normal expression levels and protein localization. Functional analysis of the mutant gene however, showed significant reduction in sterol responsiveness, indicating loss of proteolytic activity of the MBTPS2 protein.
Deleted: has not been reported before (see http://www.LOVD.nl/MBTPS2) and affects a well conserved amino acid in a highly conserved gene.
Deleted: nicely
Deleted: data not shown In total, we have studied nine families with a clinical diagnosis of KFSD and identified the same mutation in the MBTPS2 gene in 26 cases (three families). In six small families, lacking a clear X-linked mode of inheritance, the molecular basis of the disease is as yet unidentified. Although detailed clinical and histological data of these cases/families are not available, it is possible that they were misdiagnosed due to the similarity of KFSD to several other dermatological entities. Another possibility is that KFSD is a locus heterogeneous disorder and that there are other causative gene mutations. A critical review of these and other mutation negative cases may lead to other diagnosis or other loci. MBTPS2 mutations have recently been identified in IFAP patients (Oeffner et al., 2009 ). In IFAP syndrome, the clinical severity varies to a large degree, while in KFSD most affected individuals have a relatively mild phenotype. This could be due to a genotype-phenotype effect, depending on the position of the mutation in
MBTPS2. Elucidation of the MBTPS2 crystallography and its biochemical function is
necessary to make clear correlations.
Until now, the diagnosis of KFSD has been based on clinical findings and its differential diagnosis has long been under debate (Oranje et al., 1994 Deleted: Although these features had also been found in other conditions, Siemens believed this to be a distinct disorder and named it keratosis follicularis spinulosa decalvans (cum ophiasi) (Siemens HW, 1926 eral features with KFSD, but differentiation is believed to be made on a congenital nonscarring nature of the alopecia. Until now, the small number of published cases, the phenotypic variability in both IFAP and KFSD with clinical overlap and the absence of a molecular cause made it impossible to determine if these syndromes were actual variations of the same entity or truly independent disorders. Much confusion has been generated in literature because of erroneous reporting of cases with lack of clinical details and reports of autosomal modes of inheritance. For instance the case report in which KFSDlike signs were present in a boy due to an unbalanced X-chromosomal duplication led to the notion that SAT1 (Gimelli et al., 2002) was the plausible gene for KFSD (SSAT OMIM #313020). But putriscine levels and SSAT activity were normal in the Dutch KFSD family, which makes SSAT overexpression a very unlikely cause for isolated (i.e.
nonsyndromic) KFSD.
The pathogenesis of KFSD is largely unknown. An epidermal defect is highly likely since cells from the skin, hair and the cornea are involved. The epidermis has a protective function as the outer layer of the skin. The cornification of the skin's surface is compensated for by renewal of the epidermis, controlled by proliferation and differentiation of keratinocytes. As they move towards the upper layers, the keratinocytes become flatter and produce a mixture of lipids, cholesterol, free saturated fatty acids and ceramides into the intercellular spaces and thereby contributes to making the epidermis an effective barrier. Decreased cholesterol content in the stratum corneum could be attributable to the barrier function abnormality (Elias et al., 2008; Williams and Elias, 1981 (Klar et al., 2009) , lamellar ichthyosis (Lefevre et al., 2003) , harlequin ichthyosis (Kelsell et al., 2005) , Conradi-Hünermann-Happle syndrome, (Braverman et al., 1999) , CHILD syndrome (Konig et al., 2000) and X-linked Ichthyosis (Basler et al., 1992) , to which MBTPS2 is now added, causing both IFAP and KFSD.
MBTPS2 functions as a metalloprotease, required for cleavage of sterol regulatory element-binding proteins (SREBPs). Within a feedback mechanism the active domain of SREBPs is cleaved by S2P and transported to the nucleus to function as a transcription factor of several targets genes, amongst which the LDL receptor gene. For both men and women, residual protease activity of MBTPS2 will most likely determine the severity of disease. However, measurements of proteolytic activity of MBTPS2 are not straightforward. Changes in proteolytic activity may have their effect elsewhere in the sterol regulated pathway which may result in general lipid abnormalities. Our study of serum lipids in one KFSD patient does support this hypothesis but rigourous investigation in a casecontrol study is needed given all the factors which affect this pathway.
When the X-activation is skewed towards expression of the mutated allele, an Xlinked recessive disorder may affect female carriers, and the residual enzyme activity of MBTPS2 determines their phenotype. Therefore, skewed X-inactivation has been postulated as an explanation for heterogeneity in KFSD carrier females given the fact that the number of symptomatic carrier females seems larger then expected on the basis of random lyonisation. We have shown that differences in Xi-pattern expressions indeed may be correlated to the severity of KFSD symptoms in females. It is remarkable that while in some X-linked recessive diseases (Duchenne Muscular Dystrophy MIM #310200, RedGreen Colour blindness MIM + 303800/303900) females rarely show symptoms, in othDeleted: For example, mutations and deletions in the STS gene cause X-linked ichthyosis. The STS gene encodes for steroid sulfatase and serves as a metabolic precursor for estrogens, androgens, and cholesterol (Stein et al., 1989) ; (Alperin and Shapiro, 1997) . Mutations in the STS gene lead to substrate accumulation in the outer epidermis and provokes the typical scaling phenotype and permeability barrier dysfunction (Elias et al., 2004) . Furthermore, decreased cholesterol content in the stratum corneum could be attributable to the barrier function abnormality (Elias et al., 2008; Williams and Elias, 1981 (Siemens HW, 1926) . However, the distinction between different modes of X-linked inheritance is a mere quantative aspect of several underlying mechanisms, one of them being skewed Lyonisation. The standard concepts of dominance or recessiveness do often not apply to X-linked diseases (Dobyns et al., 2004) and KFSD should therefore also be simply described as X-linked inheritance.
Conclusion
This study supports a new approach towards patients who are referred to a medical clinic with KFSD or IFAP. First, critical assessment of all the symptoms together with a thorough family history is important for establishing a differential diagnosis. In patients that show the triad of follicular ichthyosis (follicular hyperkeratosis), total or subtotal atrichia of scalp, eyebrows or eyelashes and photophobia at a young age, IFAP/KFSD should be considered. When X-linked inheritance cannot be excluded, mutation analysis for MBTPS2 is warranted and will be crucial to confirm this diagnosis. To prevent more confusion in the nosology of this disorder, we propose a new name should be chosen for KFSD/IFAP syndrome and suggest this name will be used when a MBTPS2 mutation has been detected. If MBTPS2 mutation analysis is negative, the extension '-like syndrome'
should be added. This new nomenclature should be introduced when DNA analysis has been performed in enough KFSD/IFAP and KFSD/IFAP-like families and all clinical features have been reviewed.
Deleted: Although the link to nonrandom X-inactivation is evident one wonders why in some disorders this seems to go to either extreme while in others it results in extraordinary variable expression.
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